# L-ornithine L-aspartate in Overt Hepatic Encephalopathy

> **NCT01722578** · PHASE4 · COMPLETED · sponsor: **Dayanand Medical College and Hospital** · enrollment: 200 (actual)

## Conditions studied

- Cirrhosis of Liver
- Hepatic Encephalopathy

## Interventions

- **DRUG:** L-ornithine L-aspartate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01722578
- **Lead sponsor:** Dayanand Medical College and Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2017-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01722578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01722578, "L-ornithine L-aspartate in Overt Hepatic Encephalopathy". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT01722578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*